Creative Planning’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485K Buy
10,447
+2,262
+28% +$81.4K ﹤0.01% 3211
2026
Q1
$201K Sell
8,185
-123
-1% -$2.91K ﹤0.01% 3734
2025
Q4
$206K Sell
8,308
-21,793
-72% -$579K ﹤0.01% 3527
2025
Q3
$853K Buy
30,101
+21,202
+238% +$575K ﹤0.01% 2265
2025
Q2
$221K Sell
8,899
-1,578
-15% -$44.4K ﹤0.01% 3149
2025
Q1
$325K Buy
+10,477
New +$349K ﹤0.01% 2681

Other funds holding ASTH

Creative Planning's ASTH Position: Q2 2026 in Review

Creative Planning increased its Astrana Health (ASTH) stake by 28% in Q2 2026, buying an estimated $81.4K and bringing the position to 10,447 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #3211.

Creative Planning first reported a position in ASTH in Q1 2025 and has held it in 6 quarters since. The position peaked at $853K in Q3 2025. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Creative Planning held 10,447 shares of Astrana Health worth $485K as of Q2 2026.
  • Creative Planning bought 2,262 Astrana Health shares in Q2 2026, an estimated $81.4K.
  • Astrana Health made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3211 holding.
  • Creative Planning first reported a position in Astrana Health in Q1 2025 and has held it in 6 quarters since.
  • Creative Planning's Astrana Health position peaked at $853K in Q3 2025.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.